Live feed08:30:00·31mPRReleasevia QuantisnowAngioDynamics Receives FDA IDE Approval for RELIEF Feasibility Study Evaluating NanoKnife IRE Platform as Minimally Invasive Treatment for Benign Prostatic Hyperplasia (BPH)ByQuantisnow·Wall Street's wire, on your screen.ANGO· AngioDynamics Inc.Health Care
